STRATA Skin Sciences, Inc. to Report Fiscal 2017 Financial Results on Thursday, March 29

-- Conference Call to Follow at 4:30 p.m. EDT --

HORSHAM, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fiscal 2017 financial results on Thursday, March 29, after the market close.  STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress.

Conference Call Details:

Date:                            Thursday, March 29

Time:                            4:30 pm Eastern Time

Toll Free:                      888-394-8218

International:                323-794-2149

Passcode:                     6380302

Webcast:                      www.strataskinsciences.com

About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)

STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market.  Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.

Frank McCaney, Chief Executive Officer

STRATA Skin Sciences, Inc.

Bob Yedid, Managing Director

LifeSci Advisors, LLC